“As a quid pro quo, pharmaceutical manufacturers shall be required to publish the Maximum Recommended Retail Price agreed among manufacturers, wholesalers and retailers. Whilst this measure is intended to provide transparency in the pricing of essential drugs, it should, thus, not be misconstrued as price control,” Prof Ncube said.